Literature DB >> 12614395

Seizure control and cognitive outcome after temporal lobectomy: a comparison of classic Ammon's horn sclerosis, atypical mesial temporal sclerosis, and tumoral pathologies.

Michele K York1, Gayle M Rettig, Robert G Grossman, Winifred J Hamilton, Dawna D Armstrong, Harvey S Levin, Eli M Mizrahi.   

Abstract

PURPOSE: Neuropathologic examination of resected tissue after anterior temporal lobectomy (ATL) for treatment of complex partial seizures revealed several distinct histologic substrates. Our study examined the relation between neuropathology, seizure control, and cognition in ATL patients and described preliminary profiles to aid in the prediction of outcome.
METHODS: Of the 149 patients who underwent ATL from 1980 to 1999, long-term follow-up was available for 145. Specimens from 124 of the 145 patients had histologic findings consistent with one of three diagnoses: classic Ammon's horn sclerosis (cAHS; n = 75), atypical mesial sclerosis (Atypical; n = 21), or low-grade tumor (Tumor; n = 28). The other 20 patients had diverse pathologies that were insufficient for analysis. ATL patients underwent a complete preoperative and 68 underwent a postoperative neuropsychological evaluation.
RESULTS: Of the 145 patients, 84% of cAHS, 57% of Tumor, and 29% of Atypical patients had a > or =95% reduction in seizure frequency. Neuropsychological testing suggested that cAHS patients demonstrate more generalized preoperative cognitive impairment than do the Atypical or Tumor patients. The Atypical group recalled significantly less nonverbal material after surgery than did the cAHS or Tumor groups. Stratification by both pathology and surgery side revealed that the right Atypical patients declined more on information processing and set shifting.
CONCLUSIONS: Patients with cAHS or Tumor demonstrated better seizure control and fewer declines in cognitive functioning after ATL than did the Atypical patients, highlighting the need to investigate this group as a distinct entity.

Entities:  

Mesh:

Year:  2003        PMID: 12614395     DOI: 10.1046/j.1528-1157.2003.33902.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  5 in total

1.  The symptom burden of primary brain tumors: evidence for a core set of tumor- and treatment-related symptoms.

Authors:  Terri S Armstrong; Elizabeth Vera-Bolanos; Alvina A Acquaye; Mark R Gilbert; Harshad Ladha; Tito Mendoza
Journal:  Neuro Oncol       Date:  2015-08-19       Impact factor: 12.300

2.  A componential analysis of proverb interpretation in patients with frontal lobe epilepsy and temporal lobe epilepsy: relationships with disease-related factors.

Authors:  Carrie R McDonald; Dean C Delis; Joel H Kramer; Evelyn S Tecoma; Vicente J Iragui
Journal:  Clin Neuropsychol       Date:  2007-06-26       Impact factor: 3.535

3.  A stereological study of synapse number in the epileptic human hippocampus.

Authors:  Lidia Alonso-Nanclares; Asta Kastanauskaite; Jose-Rodrigo Rodriguez; Juncal Gonzalez-Soriano; Javier Defelipe
Journal:  Front Neuroanat       Date:  2011-02-24       Impact factor: 3.856

4.  More Severe Extratemporal Damages in Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis Than That With Other Lesions: A Multimodality MRI Study.

Authors:  Wei Wei; Zhiqiang Zhang; Qiang Xu; Fang Yang; Kangjian Sun; Guangming Lu
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

Review 5.  Neuropsychological features of lesion-related epilepsy in adults: an overview.

Authors:  Chris E Morrison; Luba Nakhutina
Journal:  Neuropsychol Rev       Date:  2007-10-19       Impact factor: 6.940

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.